API exports surpass imports by value in 2020-21
The govt has rolled out three schemes for promoting the manufacture of API
The govt has rolled out three schemes for promoting the manufacture of API
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
Revenue from Operations for Q3 FY25 was Rs. 454.33 crore,
Subscribe To Our Newsletter & Stay Updated